98 results
425
EX-10.3
KTRA
Kintara Therapeutics Inc
3 Apr 24
Business combination disclosure
7:15am
425
EX-10.2
KTRA
Kintara Therapeutics Inc
3 Apr 24
Business combination disclosure
7:15am
425
EX-10.4
KTRA
Kintara Therapeutics Inc
3 Apr 24
Business combination disclosure
7:15am
425
EX-10.1
KTRA
Kintara Therapeutics Inc
3 Apr 24
Business combination disclosure
7:15am
8-K
EX-10.4
KTRA
Kintara Therapeutics Inc
3 Apr 24
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
7:09am
8-K
EX-10.1
kfhroddtn2uh 8k8
3 Apr 24
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
7:09am
8-K
EX-10.2
vjrguyf8iyhcuxz3uh7
3 Apr 24
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
7:09am
8-K
EX-10.3
tc4horw3l3
3 Apr 24
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
7:09am
8-K
EX-10.2
vqu6e
3 Aug 22
Kintara Therapeutics Enters Into Equity Purchase Agreement for Up to $20 Million with Lincoln Park Capital
4:06pm
8-K
EX-10.1
t18za3b
3 Aug 22
Kintara Therapeutics Enters Into Equity Purchase Agreement for Up to $20 Million with Lincoln Park Capital
4:06pm
8-K
EX-10.1
fjb xta2mql
24 May 22
Departure of Directors or Certain Officers
8:31am
8-K
EX-10.2
0zt3l6
13 Apr 22
Kintara Announces $8.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:15pm
8-K
EX-10.1
csptgmdvvh9d5 ksinuj
13 Apr 22
Kintara Announces $8.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:15pm
8-K
EX-10.2
6bu0gp2d rm734f6dsbj
12 Nov 21
Departure of Directors or Certain Officers
6:02am
8-K
EX-10.1
ykik75ac0l4pqhdi6h
12 Nov 21
Departure of Directors or Certain Officers
6:02am
8-K
EX-10.2
b7z spb01
27 Sep 21
Kintara Announces $15.0 million Offering of Common Stock and Warrants Priced at a Premium to Market
9:41pm
8-K
EX-10.1
dpw pfn53l51ngfx7qby
27 Sep 21
Kintara Announces $15.0 million Offering of Common Stock and Warrants Priced at a Premium to Market
9:41pm